Filing Details
- Accession Number:
- 0001232524-17-000181
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-21 17:27:30
- Reporting Period:
- 2017-11-17
- Accepted Time:
- 2017-11-21 17:27:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1253886 | G Patrick Enright | 5Th Fl, Waterloo Exchange Waterloo Rd Dublin 4 L2 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2017-11-17 | 352 | $133.19 | 1,365 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 4,323 | Indirect | By Longitude Capital |
| Ordinary Shares | 215,677 | Indirect | By Longitude Venture |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The Reporting Person is a managing member of Longitude Capital Partners, LLC, the general partner each of Longitude Venture Partners, L.P. ("Longitude Venture") and Longitude Capital Associates, L.P. ("Longitude Capital"). The Reporting Person disclaims beneficial ownership of the securities of the Issuer held by Longitude Venture and Longitude Capital, except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
